Daewoong Pharmaceutical Co Ltd (069620) – Strategy, SWOT and Corporate Finance Report

Daewoong Pharmaceutical Co Ltd (069620) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Daewoong Pharmaceutical Co Ltd (Daewoong Pharmaceutical), a subsidiary of Daewoong Co Ltd, is a manufacturer and distributor of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, healthcare products and APIs. The company produces products in the form of tablets, capsules, ointments, injections, liquids, and sprays. It offers products for conditions such as bone and joint diseases, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory system remedies. It also carries out the development and commercialization of products through in-licensing, co-marketing and co-promotion. The company operates in Japan, the US, Canada, Switzerland, Germany, besides Indonesia, China, Vietnam, Israel, Thailand, and India in Asia. Daewoong Pharmaceutical is headquartered in Seoul, South Korea.

Scope

• Detailed information on Daewoong Pharmaceutical Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Daewoong Pharmaceutical Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Daewoong Pharmaceutical Co Ltd including a breakdown and examination of key business segments

• News about Daewoong Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Daewoong Pharmaceutical Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Daewoong Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Daewoong Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Yuhan Corp

Huons Global Co Ltd

Jeil Pharmaceutical Co Ltd

Bukwang Pharmaceutical Co Ltd

Sam Chun Dang Pharm Co Ltd

Yungjin Pharm Co Ltd

Dong-A Socio Holdings Co Ltd

DAE HWA Pharmaceutical Co Ltd

GC Biopharma Corp

Jeil Pharmaceutical Co Ltd

Dong-A Socio Holdings Co Ltd

Yungjin Pharm Co Ltd

DAE HWA Pharmaceutical Co Ltd

Bukwang Pharmaceutical Co Ltd

GC Biopharma Corp

Yuhan Corp

Sam Chun Dang Pharm Co Ltd

Huons Global Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Daewoong Pharmaceutical Co Ltd - Key Facts

Daewoong Pharmaceutical Co Ltd - Key Employees

Daewoong Pharmaceutical Co Ltd - Key Employee Biographies

Daewoong Pharmaceutical Co Ltd - Major Products and Services

Daewoong Pharmaceutical Co Ltd - History

Daewoong Pharmaceutical Co Ltd - Company Statement

Daewoong Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Daewoong Pharmaceutical Co Ltd - Business Description

Business Segment: Others

Performance

Business Segment: Pharmaceutical Manufacturing and Sales

Performance

Business Segment: Service Provision/Provided

Performance

Geographical Segment: Domestic Consumption

Performance

Geographical Segment: Export

Performance

R&D Overview

Daewoong Pharmaceutical Co Ltd - Corporate Strategy

Daewoong Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Daewoong Pharmaceutical Co Ltd - Strengths

Daewoong Pharmaceutical Co Ltd - Weaknesses

Daewoong Pharmaceutical Co Ltd - Opportunities

Daewoong Pharmaceutical Co Ltd - Threats

Daewoong Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Daewoong Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Feb 19, 2023: Daewoong Pharmaceutical Reaches Sales of KRW

1.16 Trillion in 2022 Fexuclue Leads The Highest Revenue

Jan 31, 2023: Daewoong and CSP sign licence deal for IPF therapy in Greater China region

Nov 15, 2022: Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue

Jul 28, 2022: Daewoong Pharmaceutical revs up the growth engine for Nabota, achieving the highest quarterly performance ever

May 05, 2022: Daewoong Pharmaceutical announced first-quarter 2022 results

Feb 21, 2022: Daewoong Pharmaceutical posts record annual revenue in 2021, with export growth of nabota and new drug development

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Daewoong Pharmaceutical Co Ltd, Key Facts

Daewoong Pharmaceutical Co Ltd, Key Employees

Daewoong Pharmaceutical Co Ltd, Key Employee Biographies

Daewoong Pharmaceutical Co Ltd, Major Products and Services

Daewoong Pharmaceutical Co Ltd, History

Daewoong Pharmaceutical Co Ltd, Other Locations

Daewoong Pharmaceutical Co Ltd, Subsidiaries

Daewoong Pharmaceutical Co Ltd, Joint Venture

Daewoong Pharmaceutical Co Ltd, Key Competitors

Daewoong Pharmaceutical Co Ltd, Ratios based on current share price

Daewoong Pharmaceutical Co Ltd, Annual Ratios

Daewoong Pharmaceutical Co Ltd, Annual Ratios (Cont…1)

Daewoong Pharmaceutical Co Ltd, Annual Ratios (Cont…2)

Daewoong Pharmaceutical Co Ltd, Interim Ratios

Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Daewoong Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Daewoong Pharmaceutical Co Ltd, Performance Chart (2018 – 2022)

Daewoong Pharmaceutical Co Ltd, Ratio Charts

Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports